High Efficiency CRISPR/Cas9-mediated Gene Editing in Primary Human T-cells Using Mutant Adenoviral E4orf6/E1b55k "Helper" Proteins.

Many future therapeutic applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 and related RNA-guided nucleases are likely to require their use to promote gene targeting, thus necessitating development of methods that provide for delivery of three components-Cas9, guide RNAs and recombination templates-to primary cells rendered proficient for homology-directed repair. Here, we demonstrate an electroporation/transduction codelivery method that utilizes mRNA to express both Cas9 and mutant adenoviral E4orf6 and E1b55k helper proteins in association with adeno-associated virus (AAV) vectors expressing guide RNAs and recombination templates. By transiently enhancing target cell permissiveness to AAV transduction and gene editing efficiency, this novel approach promotes efficient gene disruption and/or gene targeting at multiple loci in primary human T-cells, illustrating its broad potential for application in translational gene editing.

[1]  M. Weitzman,et al.  Distinct Requirements of Adenovirus E1b55K Protein for Degradation of Cellular Substrates , 2008, Journal of Virology.

[2]  Israel Steinfeld,et al.  Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells , 2015, Nature Biotechnology.

[3]  A. Scharenberg,et al.  Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template , 2015, Science Translational Medicine.

[4]  D. Duan,et al.  Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction. , 1999, Human gene therapy.

[5]  L. Hanakahi,et al.  Adenovirus E4 34k and E1b 55k Oncoproteins Target Host DNA Ligase IV for Proteasomal Degradation , 2007, Journal of Virology.

[6]  B. Ferguson,et al.  Functions of DNA damage machinery in the innate immune response to DNA virus infection. , 2015, Current opinion in virology.

[7]  Claudio Mussolino,et al.  TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity , 2014, Nucleic acids research.

[8]  M. Weitzman,et al.  The Mre11/Rad50/Nbs1 Complex Limits Adeno-Associated Virus Transduction and Replication , 2007, Journal of Virology.

[9]  D. Russell,et al.  AAV-mediated gene targeting methods for human cells , 2011, Nature Protocols.

[10]  R. Samulski,et al.  Insight into the Mechanism of Inhibition of Adeno-Associated Virus by the Mre11/Rad50/Nbs1 Complex , 2014, Journal of Virology.

[11]  Konstantin M. J. Sparrer,et al.  Intracellular detection of viral nucleic acids. , 2015, Current opinion in microbiology.

[12]  Morgan L. Maeder,et al.  Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy. , 2015, Human gene therapy.

[13]  Francisco J. Sánchez-Rivera,et al.  Applications of the CRISPR–Cas9 system in cancer biology , 2015, Nature Reviews Cancer.

[14]  David Baker,et al.  megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering , 2013, Nucleic acids research.

[15]  Q. Wang,et al.  Cytosolic sensing of aberrant DNA: arming STING on the endoplasmic reticulum , 2015, Expert opinion on therapeutic targets.

[16]  I. Alexander,et al.  Adeno-associated virus serotypes for gene therapeutics. , 2015, Current opinion in pharmacology.

[17]  Aymeric Duclert,et al.  Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies. , 2015, Cancer research.

[18]  G. Ketner,et al.  Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase. , 1999, Virology.

[19]  J. Hauber,et al.  mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5 , 2015, Nucleic acids research.

[20]  G. Melino,et al.  Genome-editing tools for stem cell biology , 2015, Cell Death and Disease.

[21]  A. Baiker,et al.  Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. , 2012, Human gene therapy methods.

[22]  Neville E. Sanjana,et al.  High-throughput functional genomics using CRISPR–Cas9 , 2015, Nature Reviews Genetics.

[23]  I. Cristea,et al.  Blowing Off Steam: Virus Inhibition of cGAS DNA Sensing. , 2015, Cell host & microbe.

[24]  R. Doms,et al.  Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. , 2014, Blood.

[25]  Lu-ping Liu,et al.  A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila. , 2015, Journal of genetics and genomics = Yi chuan xue bao.

[26]  Jennifer A. Doudna,et al.  Generation of knock-in primary human T cells using Cas9 ribonucleoproteins , 2015, Proceedings of the National Academy of Sciences.

[27]  David V. Schaffer,et al.  Engineering adeno-associated viruses for clinical gene therapy , 2014, Nature Reviews Genetics.

[28]  M. Weitzman,et al.  The Adenovirus E1b55K/E4orf6 Complex Induces Degradation of the Bloom Helicase during Infection , 2010, Journal of Virology.

[29]  L. Vandenberghe,et al.  Adeno-associated virus: fit to serve. , 2014, Current opinion in virology.

[30]  Wenyan Jiang,et al.  CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems. , 2015, Annual review of microbiology.

[31]  Gabriela Plesa,et al.  Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5. , 2013, Human gene therapy.

[32]  M. Weitzman,et al.  Adenovirus oncoproteins inactivate the Mre11–Rad50–NBS1 DNA repair complex , 2002, Nature.

[33]  Wei-Ting Hwang,et al.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. , 2014, The New England journal of medicine.